Aktis Oncology
AKTS
#5665
Rank
NZ$2.33 B
Marketcap
NZ$42.19
Share price
-0.28%
Change (1 day)
N/A
Change (1 year)

Revenue for Aktis Oncology (AKTS)

Revenue in 2026 (TTM): NZ$13.04 Million

According to Aktis Oncology's latest financial reports the company's current revenue (TTM ) is NZ$12.84 Million. In 2025 the company made a revenue of NZ$11.16 Million an increase over the revenue in the year 2024 that were of NZ$2.55 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aktis Oncology from 2022 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) NZ$13.04 M16.84%
2025 NZ$11.16 M336.92%
2024 NZ$2.55 M
2023 N/A
2022N/A